DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /PI3K/Akt/mTOR PathwayPI3K/Akt/mTOR Pathway
  5. /AktAkt
  6. /ZandelisibZandelisib
Chemical structure of CAS 1401436-95-0

Zandelisib

In Stock•Starting at $257 for 1 mg•Purity ≥ 98%
CAS No.1401436-95-0
MDL No.N/A
MFC31H38F2N8O
MW576.70
InChI KeyWPFUFWIHMYZXSF-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98%$257In Stock
5 mg98%$605In Stock
10 mg98%$920In Stock
25 mg98%$1487In Stock
50 mg98%$2011In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1401436-95-0
Product NameZandelisib

Biological Targets

PIK3CD

Associated Conditions

neoplasm of mature B-cells·diffuse large B-cell lymphoma·Mantle cell lymphoma·cancer·B-cell acute lymphoblastic leukemia·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Safety, Pharmacokinetics, and Pharmacodynamics of ME-401, an Oral, Potent, and Selective Inhibitor of Phosphatidylinositol 3-Kinase P110δ, Following Single Ascending Dose Administration to Healthy Volunteers.

Clinical therapeutics • Vol. 40, Issue 11 • 2018
PMID: 30458930DOI: 10.1016/j.clinthera.2018.09.006

Facilitation of the growth of an allogeneic tumour by suppressor cells in newborn rats.

The Australian journal of experimental biology and medical science • Vol. 53, Issue 5 • 1976
PMID: 7221DOI: 10.1038/icb.1975.47

Documentation

Similar Products

  • 2-(Difluoromethyl)-1-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-1H-benzimidazole

    CAS No.475110-96-4

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact